Search - tctmd.com

Displaying 61 - 80 of 665

Sort: Relevancy | Date

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

Presenter: Adrian P. Banning, Ted Feldman, Daniel J. Blackman

November 01, 2017

Presentation TCT 2017

When to Use Cerebral Protection During TAVR

Presenter: Alfredo Trento, Alexandra J. Lansky

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Presenter: Adrian P. Banning, Ted Feldman, Eberhard Grube

November 01, 2017

Presentation TCT 2017

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Presenter: Alfredo Trento, David J. Cohen

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Presenter: Adrian P. Banning, Ted Feldman, Bernard Prendergast

November 01, 2017

Presentation TCT 2017

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jonathon A. Leipsic, Maurice E. Sarano, Hasan Jilaihawi

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Presenter: Adrian P. Banning, Ted Feldman, Raj Makkar

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis

Presenter: Bernard Prendergast, Brian K. Whisenant, Victoria Delgado

November 01, 2017

Presentation TCT 2017

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Presenter: Bernard Prendergast, Brian K. Whisenant, Allan Schwartz

November 01, 2017

Presentation TCT 2017

Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR?

Presenter: Bernard Prendergast, Brian K. Whisenant, David J. Cohen

November 01, 2017

Presentation TCT 2017

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Presenter: Bernard Prendergast, Brian K. Whisenant, Eric Van Belle

November 01, 2017

Presentation TCT 2017

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

Presenter: Bernard Prendergast, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Venezuela Presents: A Complex Vascular Complication During TAVI - Solution and Lessons Learned

Presenter: Waqar H. Ahmed, Oscar A. Mendiz, Carlos D Calderas

November 01, 2017

Presentation TCT 2017

Identifying Optimal Patients for Minimalist TAVR Clinical and Anatomic Guidelines

Presenter: Charles J. Davidson, Mathew Williams, Ruby Satpathy

November 01, 2017

Presentation TCT 2017

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

Presenter: Charles J. Davidson, Mathew Williams, Julia Seeger

November 01, 2017

Presentation TCT 2017

Borderline Valve Sizing Dilemmas The In-Between Size and Too Large Annulus

Presenter: Charles J. Davidson, Mathew Williams, Albert Markus Kasel

November 01, 2017

Presentation TCT 2017

Alternative (Non-femoral) Vascular Access for TAVR Choices and Preferences

Presenter: Charles J. Davidson, Mathew Williams, Daniel J. Blackman

November 01, 2017

Presentation TCT 2017

Adjunctive Pharmacotherapy after TAVR Settled and Unsettled Issues

Presenter: Charles J. Davidson, Mathew Williams, Luis Nombela-Franco

November 01, 2017

Advertisement

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

When to Use Cerebral Protection During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Post-TAVR Valve Thickening: Current Data and Open Questions

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Live From Denver: TCT 2017, Day Three

Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR?

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

Venezuela Presents: A Complex Vascular Complication During TAVI - Solution and Lessons Learned

Identifying Optimal Patients for Minimalist TAVR Clinical and Anatomic Guidelines

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

Borderline Valve Sizing Dilemmas The In-Between Size and Too Large Annulus

Alternative (Non-femoral) Vascular Access for TAVR Choices and Preferences

Adjunctive Pharmacotherapy after TAVR Settled and Unsettled Issues

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content